Skip to content
value.today

Amgen Inc. vs AstraZeneca PLC

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Amgen Inc. and AstraZeneca PLC are worth about the same: $249.2 B and $242.6 B (market caps of Oct 30, 2026 for Amgen Inc. and Aug 1, 2026 for AstraZeneca PLC). AstraZeneca PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • AstraZeneca PLC had more revenue: $58.7 B against $36.8 B for Amgen Inc., both in the year to December 2025.
  • AstraZeneca PLC earned more: net income of $10.2 B against $7.7 B for Amgen Inc.
  • Amgen Inc. keeps more of each dollar of sales: a net margin of 21.0% against 17.4% for AstraZeneca PLC.
  • AstraZeneca PLC employs more people: 89,900 against 25,200 at Amgen Inc. Each employee brings in about $1,458,373 of revenue at Amgen Inc. and $653,382 at AstraZeneca PLC.
  • On price to earnings, Amgen Inc. trades at 26.5× and AstraZeneca PLC at 23.7×: investors pay more for each dollar of Amgen Inc.'s profit.
  • Amgen Inc.'s revenue grew faster in its latest fiscal year: +9.9% against +8.6% for AstraZeneca PLC.
  • On the Piotroski F-score, a nine-point test of improving finances, Amgen Inc. scores 7 and AstraZeneca PLC 8. Their Altman Z-scores put Amgen Inc. in the grey zone and AstraZeneca PLC in the safe zone.
  • Dividend yield: 2.06% for Amgen Inc. and 2.05% for AstraZeneca PLC.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

045901341792020202120222023202420252026Amgen Inc. 173AstraZeneca PLC 179

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$15B$29B$44B$59B201720182019202020212022202320242025Amgen Inc. $37BAstraZeneca PLC $59B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAmgen Inc.
AMGN · #73 in the world
AstraZeneca PLC
AZN · #76 in the world
Profile
Country🇺🇸 USA🇬🇧 UK
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded19801999
Size
Market cap$249.2 B$242.6 B
Revenue$36.8 B$58.7 B
Net income$7.7 B$10.2 B▲ best
Employees25,20089,900
Valuation
P/E ratio26.5×23.7×
Price to sales6.4×4.1×
Price to book28.8×5.0×
Free cash flow yield3.3%4.8%▲ best
Profitability
Gross margin67.3%81.9%▲ best
Operating margin24.7%▲ best23.4%
Net margin21.0%▲ best17.4%
Return on equity106.1%▲ best22.9%
Return on invested capital14.4%17.5%▲ best
Growth
Revenue growth9.9%▲ best8.6%
Revenue growth, 3 years a year11.8%▲ best9.8%
Earnings per share growth88.2%▲ best45.3%
Financial strength
Debt to equity6.3×0.5×▲ best
Net debt to EBITDA3.2×—
Interest cover3.3×8.1×▲ best
Cash
Free cash flow margin22.0%▲ best20.0%
Shareholder returns
Dividend yield2.1%▲ best2.0%
Shareholder yield2.1%2.3%▲ best
Strength scores
Piotroski F-score7 of 98 of 9▲ best
Altman Z-score zonegreysafe
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Aug 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Amgen Inc. or AstraZeneca PLC?

Amgen Inc. and AstraZeneca PLC are worth about the same: $249.2 B and $242.6 B (market caps of Oct 30, 2026 for Amgen Inc. and Aug 1, 2026 for AstraZeneca PLC). AstraZeneca PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, Amgen Inc. or AstraZeneca PLC?

AstraZeneca PLC had more revenue: $58.7 B against $36.8 B for Amgen Inc., both in the year to December 2025. AstraZeneca PLC earned more: net income of $10.2 B against $7.7 B for Amgen Inc.

Which is more profitable, Amgen Inc. or AstraZeneca PLC?

Amgen Inc. keeps more of each dollar of sales: a net margin of 21.0% against 17.4% for AstraZeneca PLC.

Which has more employees, Amgen Inc. or AstraZeneca PLC?

AstraZeneca PLC employs more people: 89,900 against 25,200 at Amgen Inc. Each employee brings in about $1,458,373 of revenue at Amgen Inc. and $653,382 at AstraZeneca PLC.

Is Amgen Inc. cheaper than AstraZeneca PLC?

On price to earnings, Amgen Inc. trades at 26.5× and AstraZeneca PLC at 23.7×: investors pay more for each dollar of Amgen Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.

Which is growing faster, Amgen Inc. or AstraZeneca PLC?

Amgen Inc.'s revenue grew faster in its latest fiscal year: +9.9% against +8.6% for AstraZeneca PLC.

Which is financially stronger, Amgen Inc. or AstraZeneca PLC?

On the Piotroski F-score, a nine-point test of improving finances, Amgen Inc. scores 7 and AstraZeneca PLC 8. Their Altman Z-scores put Amgen Inc. in the grey zone and AstraZeneca PLC in the safe zone.

Sources#

Every figure on this page comes from these, with the date shown next to it.